EMILY HOAG: Open Payments
NPI 1487832069 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 26 payments from 12 companies in 2025. Trend: 2023 $525 · 2024 $1,684 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $131 |
| Janssen Pharmaceuticals, Inc | 3 | $111 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| Teva Pharmaceuticals USA, Inc. | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Bausch Health US, LLC | 2 | $37 |
| ABBVIE INC. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Neos Therapeutics, LP | 2 | $29 |
Products named: CAPLYTA, SPRAVATO, AUSTEDO XR, TRINTELLIX, COBENFY, Auvelity, APLENZIN, VRAYLAR.
Industry payments across IL — which companies pay providers there.
